Freya Biosciences
Latest round
- Series A
Last raised
- Sep 2024
Total raised
- $50M
Investors
- 8
About Freya Biosciences
Based in Copenhagen, Denmark, and founded in 2023 by its CEO Colleen Acosta, CSO Johan van Hylckama Vlieg, and CBO Ulrich Binné, Freya Biosciences operates as a clinical-stage company operates as a provider of biotechnology for the treatment of infertility in women with dysbiotic vaginal microbiota. Freya Biosciences offers a data science platform that employs quantitative and whole-genome sequencing, proteomic and transcriptomic immune markers, along with clinical outcomes and demographic data to develop therapeutic solutions. The company's focus areas include IVF and natural conception, endometriosis-related infertility, preterm birth, and various other women's health conditions linked to local immune dysregulation.
Who invested in Freya Biosciences
8 investors across 2 rounds
See all investors in Freya Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Freya Biosciences
Who invested in Freya Biosciences?
Freya Biosciences has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Freya Biosciences raised?
Freya Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Freya Biosciences last raise money?
Freya Biosciences's most recent round on record is a Series A, in Sep 2024.
What does Freya Biosciences do?
Based in Copenhagen, Denmark, and founded in 2023 by its CEO Colleen Acosta, CSO Johan van Hylckama Vlieg, and CBO Ulrich Binné, Freya Biosciences operates as a clinical-stage company operates as a provider of biotechnology for the treatment of infertility in women with dysbiotic vaginal microbiota.
Where is Freya Biosciences headquartered?
Freya Biosciences is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like Freya Biosciences?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Freya Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Freya Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.